Jane Street’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$241K Buy
185,250
+168,676
+1,018% +$245K ﹤0.01% 9688
2026
Q1
$24K Sell
16,574
-1,001,288
-98% -$1.59M ﹤0.01% 11161
2025
Q4
$1.4M Buy
1,017,862
+783,223
+334% +$1.64M ﹤0.01% 5448
2025
Q3
$641K Buy
+234,639
New +$834K ﹤0.01% 7309
2025
Q2
Sell
-172,534
Closed -$681K 10839
2025
Q1
$635K Buy
+172,534
New +$630K ﹤0.01% 6426
2023
Q1
Sell
-56,602
Closed -$389K 9899
2022
Q4
$389K Buy
+56,602
New +$267K ﹤0.01% 6582
2021
Q4
Sell
-10,714
Closed -$70K 10791
2021
Q3
$70K Sell
10,714
-2,656
-20% -$25.5K ﹤0.01% 9427
2021
Q2
$214K Buy
+13,370
New +$185K ﹤0.01% 8710
2020
Q3
Sell
-44,482
Closed -$86K 7885
2020
Q2
$86K Buy
+44,482
New +$91.2K ﹤0.01% 6759

Other funds holding STIM

Jane Street's STIM Position: Q2 2026 in Review

Jane Street increased its Neuronetics (STIM) stake by 1,018% in Q2 2026, buying an estimated $245K and bringing the position to 185,250 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #9688.

Jane Street first reported a position in STIM in Q2 2020 and has held it in 9 quarters since. The position peaked at $1.4M in Q4 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Jane Street held 185,250 shares of Neuronetics worth $241K as of Q2 2026.
  • Jane Street bought 168,676 Neuronetics shares in Q2 2026, an estimated $245K.
  • Neuronetics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9688 holding.
  • Jane Street first reported a position in Neuronetics in Q2 2020 and has held it in 9 quarters since.
  • Jane Street's Neuronetics position peaked at $1.4M in Q4 2025.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.